1. 0369 Effect of Lemborexant on Sleep Architecture in Older Adults with Insomnia Disorder. (12th April 2019) Authors: Moline, Margaret; Murphy, Patricia; Pinner, Kate; Cheng, Jocelyn; Perdomo, Carlos; Kumar, Dinesh; Zammit, Gary; Mayleben, David Journal: Sleep Issue: Volume 42(2019)Supplement 1 Page Start: A150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 0375 A Novel Dual Orexin Receptor Antagonist (ACT-541468) to Treat Insomnia: A Randomized, Double-Blind, Placebo-Controlled, Active-Reference Phase 2 Study. (12th April 2019) Authors: Dauvilliers, Yves; Zammit, Gary; Fietze, Ingo; Mayleben, David; Kinter, Dalma Seboek; Pain, Scott; Hedner, Jan Journal: Sleep Issue: Volume 42(2019)Supplement 1 Page Start: A152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 343 A benefit-risk assessment of daridorexant for the treatment of insomnia using patient preference data from two phase 3 trials. (3rd May 2021) Authors: Heidenreich, Sebastian; Phillips-Beyer, Andrea; Ross, Melissa; Chua, Gin Nie; Fietze, Ingo; Mayleben, David Journal: Sleep Issue: Volume 44(2021)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 344 Daridorexant Improves Total Sleep Time (TST) in Insomnia Patients Without Altering the Proportion of Sleep Stages. (3rd May 2021) Authors: Zammit, Gary; Mayleben, David; Fietze, Ingo; Pain, Scott; Kinter, Dalma Seboek; Gimona, Alberto; Dauvilliers, Yves Journal: Sleep Issue: Volume 44(2021)Supplement 2 Page Start: A137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 347 Daridorexant is Safe and Improves Both Sleep and Daytime Functioning in Elderly Patients with Insomnia. (3rd May 2021) Authors: Fietze, Ingo; Bassetti, Claudio; Mayleben, David; Gimona, Alberto; Pain, Scott; Kinter, Dalma Seboek Journal: Sleep Issue: Volume 44(2021)Supplement 2 Page Start: A138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A novel forehead temperature-regulating device for insomnia: a randomized clinical trial. Issue 5 (10th April 2018) Authors: Roth, Thomas; Mayleben, David; Feldman, Neil; Lankford, Alan; Grant, Timothy; Nofzinger, Eric Journal: Sleep Issue: Volume 41:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Assessment of morning sleep propensity with lemborexant in adults with insomnia disorder in a randomized, placebo-controlled crossover study. Issue 1 (2nd July 2021) Authors: Mayleben, David; Rosenberg, Russell; Pinner, Kate; Hussein, Ziad; Moline, Margaret Journal: Sleep advances Issue: Volume 2:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder. Issue 3 (5th February 2020) Authors: Dauvilliers, Yves; Zammit, Gary; Fietze, Ingo; Mayleben, David; Seboek Kinter, Dalma; Pain, Scott; Hedner, Jan Journal: Annals of neurology Issue: Volume 87:Issue 3(2020) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efavirenz modulation of sleep spindles and sleep spectral profile. (12th August 2014) Authors: Simen, Arthur A.; Ma, Junshui; Svetnik, Vladimir; Mayleben, David; Maynard, James; Roth, Adam; Mixson, Lori; Mogg, Robin; Shera, David; George, Laura; Mast, T. Chris; Beals, Chan; Stoch, Aubrey; Struyk, Arie; Shire, Norah; Fraser, Iain Journal: Journal of sleep research Issue: Volume 24:Number 1(2015:Mar.) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials. Issue 2 (February 2022) Authors: Mignot, Emmanuel; Mayleben, David; Fietze, Ingo; Leger, Damien; Zammit, Gary; Bassetti, Claudio L A; Pain, Scott; Kinter, Dalma Seboek; Roth, Thomas Journal: Lancet neurology Issue: Volume 21:Issue 2(2022) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗